MYRIAD GENETICS INC — Director's Dealing 2018

Jul 13, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-07-11

Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-07-11	Common Stock	M	30672	$23.11	Acquired	154869	Direct
2018-07-11	Common Stock	S	30672	$44.0	Disposed	124197	Direct
2018-07-11	Common Stock	M	40000	$23.11	Acquired	164197	Direct
2018-07-11	Common Stock	S	40000	$42.0163	Disposed	124197	Direct
2018-07-11	Common Stock	G	7623	$0.0	Disposed	116574	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-11	Non-Qualified Stock Option (right to buy)	$23.11	M	30672	Disposed	2020-03-03	Common Stock (30672)	Direct
2018-07-11	Non-Qualified Stock Option (right to buy)	$23.11	M	40000	Disposed	2020-03-03	Common Stock (40000)	Direct

Footnotes

F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.